or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    LCTX F Lineage Cell Therapeutics, Inc. -7.08
    BCAB B BioAtla, Inc. -6.23
    AGEN D Agenus Inc. -5.58
    GMAB F Genmab A/S -3.58
    APLM F Apollomics Inc. -2.15
    CGEM A Cullinan Management, Inc. -1.85
    CCCC D C4 Therapeutics, Inc. -1.68
    ADAP D Adaptimmune Therapeutics plc -1.65
    XOMA B XOMA Corporation -1.47
    EVAX D Evaxion Biotech A/S -0.51
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Medicine Pancreatic Cancer Treatment Of Non Small Cell Lung Cancer Antineoplastic Drugs Biopharmaceutical Immune System Oncology Ovarian Cancer Small Cell Lung Cancer Tumor Acute Myeloid Leukemia Advanced Solid Tumors Aging Associated Diseases Antibodies Antibody Autoimmune Disorders Biology Biotechnology

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 2.44
    CNCR C Loncar Cancer Immunotherapy ETF 1.46
    XHS C SPDR S&P Health Care Services ETF 1.36
    XHE B SPDR S&P Health Care Equipment 1.25
    HTEC D Robo Global Healthcare Technology and Innovation ETF 1.22
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare GERM to XHE Compare XHS to HTEC Compare XHS to XHE

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        May 2 GMAB Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
        May 2 GMAB Genmab A/S 2024 Q1 - Results - Earnings Call Presentation
        May 2 GMAB Genmab reports Q1 results
        May 2 GMAB Genmab Announces Financial Results for the First Quarter of 2024
        May 2 BCAB BioAtla: A Buried ADC Concern Gets Some New Life In 2024
        May 1 GMAB Genmab Q1 2024 Earnings Preview
        May 1 ADAP Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
        May 1 GMAB Genmab: A Complicated Tale
        May 1 AGEN Agenus regains compliance with Nasdaq minimum bid price requirement
        May 1 AGEN Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
        May 1 GMAB Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
        Apr 30 AGEN Time Is Running Out For Agenus To Raise Cash
        Apr 30 GMAB Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
        Apr 30 LCTX Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
        Apr 30 XOMA XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
        Apr 30 GMAB Pfizer, Genmab cervical cancer therapy wins full FDA approval
        Apr 29 GMAB TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
        Apr 29 GMAB FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
        Apr 29 LCTX Lineage Cell Therapeutics board chairman passes away
        Apr 29 LCTX Lineage Announces Changes to Board of Directors
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Small Cell Lung Cancer Biotechnology Medicine Clinical Medicine Solid Tumors Treatment Of Non Small Cell Lung Cancer Biology Cancer Treatment Immune System Immunology Immunotherapy Osteoarthritis Pancreatic Cancer Tumor Antibodies Antibody Antineoplastic Drugs Clinical Development Degenerative Disease
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags